Insider Selling: KalVista Pharmaceuticals, Inc (NASDAQ:KALV) Insider Sells 22,679 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par acquired 17,605 shares of the stock in a transaction dated Wednesday, January 3rd. The stock was acquired at an average cost of $12.20 per share, with a total value of $214,781.00. Following the completion of the transaction, the insider now owns […]
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) issued its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.76) by ($0.04), MarketWatch Earnings reports. KalVista Pharmaceuticals Stock Performance Shares of NASDAQ KALV opened at $8.16 on Friday. The company has a 50 […]
KalVista Pharmaceuticals (NASDAQ:KALV) Releases Earnings Results, Misses Expectations By $0 04 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) shares passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $10.21 and traded as low as $8.96. KalVista Pharmaceuticals shares last traded at $9.25, with a volume of 120,390 shares traded. Analysts Set New Price […]